Laboratory Corporation of America Holdings Newswire

Laboratory Corporation of America Holdings Newswire

Comprehensive Real-Time News Feed for Laboratory Corporation of America Holdings.

Results 1 - 20 of 439 in Laboratory Corporation of America Holdings

  1. Laboratory Corp. of America Holdings (LH) Price Target Increased to $132.00 by Analysts at MizuhoRead the original story w/Photo

    Yesterday | AmericanBankingNews.com

    The firm currently has a "neutral" rating on the stock. Mizuho's price target points to a potential upside of 1.84% from the stock's previous close.

    Comment?

  2. Barclays Raises Laboratory Corp. of America Holdings (LH) Price Target to $155.00Read the original story w/Photo

    Yesterday | AmericanBankingNews.com

    The firm presently has an "overweight" rating on the stock. Barclays' price objective would suggest a potential upside of 19.58% from the company's current price.

    Comment?

  3. Laboratory Corp. of America Holdings (LH) PT Raised to $131.00Read the original story w/Photo

    Yesterday | AmericanBankingNews.com

    ... The stock has an average rating of "Buy" and an average target price of $135.50. Laboratory Corporation of America Holdings is an independent clinical laboratory company in the United States. Through a national network of laboratories, the Company ...

    Comment?

  4. EXACT Sciences Co. (EXAS) Lifted to "Buy" at Zacks Investment ResearchRead the original story w/Photo

    Yesterday | AmericanBankingNews.com

    ... use in the detection of cancer. Certain of its technologies have been licensed to Laboratory Corporation of America Holdings for a stool-based DNA screening assay for colorectal cancer in the average-risk population. Colorectal cancer, which is the ...

    Comment?

  5. Additional reports in Kedarie Johnson case submitted to DCIRead the original story w/Photo

    Thursday Jun 23 | Hawk Eye

    Charges against two people Burlington police believe are responsible for Kedarie Johnson's murder March 2 have been delayed while a state crime lab examines new evidence.

    Comment?

  6. FY2017 EPS Estimates for Laboratory Corp. of America Holdings (LH) Increased by AnalystRead the original story w/Photo

    Wednesday Jun 22 | Daily Political

    ... company, valued at $34,714,880. The disclosure for this sale can be found here . Laboratory Corporation of America Holdings is an independent clinical laboratory company in the United States. Through a national

    Comment?

  7. FY2017 EPS Estimates for Laboratory Corp. of America Holdings Raised by KeyBancRead the original story w/Photo

    Tuesday Jun 21 | AmericanBankingNews.com

    Laboratory Corp. of America Holdings - Equities research analysts at KeyBanc boosted their FY2017 earnings per share estimates for shares of Laboratory Corp. of America Holdings in a research note issued to investors on Sunday, according to Zacks Investment Research . KeyBanc analyst D. Hooker now anticipates that the firm will post earnings of $10.22 per share for the year, up from their previous forecast of $10.02.

    Comment?

  8. Top Picks of Healthcare-focused Asset Manager Run by Former SAC Capital TradersRead the original story w/Photo

    Tuesday Jun 21 | Insider Monkey

    Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages. We only allow registered users to use ad blockers.

    Comment?

  9. EXACT Sciences (EXAS) - Research Analysts' Weekly Ratings UpdatesRead the original story w/Photo

    Monday Jun 20 | AmericanBankingNews.com

    ... use in the detection of cancer. Certain of its technologies have been licensed to Laboratory Corporation of America Holdings for a stool-based DNA screening assay for colorectal cancer in the average-risk population. Colorectal cancer, which is the ...

    Comment?

  10. Encompass Compliance Corporation (ENCC) Hires Schoonover as Chief Operating OfficerRead the original story w/Photo

    Monday Jun 20 | Market Wire

    Encompass Compliance Corporation announces that it has made an addition to its management team, hiring Mr. James Schoonover as its Chief Operating Officer. James A. Schoonover, 59, comes to ENCC after a 16 year career with MEDTOX Scientific, which was sold to Laboratory Corporation of America in 2012.

    Comment?

  11. Cell-Free DNA (cfDNA) Testing Global Market - Forecast to 2022Read the original story w/Photo

    Thursday Jun 16 | PR Newswire

    The groundbreaking discovery of cfDNA in 1948 has opened up to new possibilities in the field of gynecology, oncology, transplantation and infectious diseases. The cell-free DNA testing global market is segmented based on the type, applications and geography.

    Comment?

  12. David P. King Sells 196,400 Shares of Laboratory Corp. of America Holdings (LH) StockRead the original story w/Photo

    Wednesday Jun 15 | AmericanBankingNews.com

    ... worth $14,838,000 after buying an additional 33,875 shares in the last quarter. Laboratory Corporation of America Holdings is an independent clinical laboratory company in the United States. Through a national network of laboratories, the Company ...

    Comment?

  13. Laboratory Corp. of America Holdings (LH) Releases FY16 Earnings GuidanceRead the original story w/Photo

    Tuesday Jun 14 | Daily Political

    ... at approximately $2,892,154.35. The disclosure for this sale can be found here . Laboratory Corporation of America Holdings is an independent clinical laboratory company in the United States. Through a national network of laboratories, the Company ...

    Comment?

  14. Laboratory Corp. of America Holdings (LH) Updates FY16 Earnings GuidanceRead the original story w/Photo

    Tuesday Jun 14 | AmericanBankingNews.com

    ... at approximately $2,892,154.35. The disclosure for this sale can be found here . Laboratory Corporation of America Holdings is an independent clinical laboratory company in the United States. Through a national network of laboratories, the Company ...

    Comment?

  15. Global Cell-Free DNA Testing Market - Forecast to 2022; New Report LaunchedRead the original story w/Photo

    Tuesday Jun 14 | SBWire

    Cell-free DNA are small fragments of DNA circulating freely in the blood and body fluids which are utilized as a valuable biomarker to advance personalized medicine, and improve the quality of life. The groundbreaking discovery of cfDNA in 1948 has opened up to new possibilities in the field of gynecology, oncology, transplantation and infectious diseases.

    Comment?

  16. Laboratory Corp. of America Holdings (LH) Earns "Outperform" Rating from Credit SuisseRead the original story w/Photo

    Tuesday Jun 14 | Daily Political

    ... The stock has an average rating of Buy and a consensus target price of $135.50. Laboratory Corporation of America Holdings is an independent clinical laboratory company in the United States. Through a national network of laboratories, the Company ...

    Comment?

  17. New Market Study, "Fragile X Syndrome Global Clinical Trials Review, H1, 2016", Has Been PublishedRead the original story w/Photo

    Tuesday Jun 14 | SBWire

    ... Ltd., Alcobra Ltd, Zynerba Pharmaceuticals, Inc., Marinus Pharmaceuticals, Inc., Laboratory Corporation of America Holdings, Autism Therapeutics LLC, Autism Speaks, Inc., AMO Pharma Limited About Fast Market Research Fast Market Research is a ...

    Comment?

  18. Monetary Management Group Inc. Has $328,000 Position in Laboratory Corp. of America HoldingsRead the original story w/Photo

    Monday Jun 13 | Daily Political

    Monetary Management Group Inc. reduced its stake in Laboratory Corp. of America Holdings by 6.4% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission . The institutional investor owned 2,800 shares of the company's stock after selling 190 shares during the period.

    Comment?

  19. Cell-Free DNA (cfDNA) Testing Market Analysis and Forecasts to 2022Read the original story

    Friday Jun 10 | Freshnews

    Cell-free DNA are small fragments of DNA circulating freely in the blood and body fluids which are utilized as a valuable biomarker to advance personalized medicine, and improve the quality of life. The groundbreaking discovery of cfDNA in 1948 has opened up to new possibilities in the field of gynecology, oncology, transplantation and infectious diseases.

    Comment?

  20. Global Cell-Free DNA (cfDNA) Testing Market 2016 Share, Trend, Segmentation and Forecast to 2022Read the original story

    Friday Jun 10 | World News Report

    PUNE, INDIA, June 10, 2016 / EINPresswire.com / -- Cell-free DNA are small fragments of DNA circulating freely in the blood and body fluids which are utilized as a valuable biomarker to advance personalized medicine, and improve the quality of life. The groundbreaking discovery of cfDNA in 1948 has opened up to new possibilities in the field of gynecology, oncology, transplantation and infectious diseases.

    Comment?